I believe it is well overdue. If they're so encou
Post# of 72440
(Total Views: 331)
Posted On: 02/28/2018 8:03:38 AM
I believe it is well overdue. If they're so encouraged by the data meeting endpoints they decided to cut the trial short, it could have a few of the CDA's mouths watering. I know it'll take some time of course, but very much looking forward to see IPIX get a new presentation together. And seeing it taken into a small 2c trial before the big trial. Once the oral formulation is ready, we could see kevetrin's data and future in a journal. I think it makes it there sooner than later.
Quote:
Do you think the Kevetrin results will be published in a Medical Journal? Seems like a logical next step.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼